Jill Wilson joined Ionetix in 2018 initially to lead the company’s first FDA submission and develop their QA program before being elevated to her current position as Vice President of Regulatory Affairs & Quality Assurance. Prior to joining Ionetix, she spent 17 years in the PET industry at SOFIE (formerly IBA Molecular NA) holding various escalating leadership roles in the operations, quality and regulatory departments. Ms. Wilson has extensive experience in PET drug lifecycle management, having written and submitted multiple PET ANDAs and directing them through successful approval. Additionally, she has directly participated and overseen over 30 FDA inspections. Ms. Wilson has a BA in Consumer Affairs from Montclair State University and maintains a RAC certification.